Cubist Systematic Strategies, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.5 - $1.06 $9,900 - $20,988
-19,800 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.92 - $1.22 $6,624 - $8,784
7,200 Added 57.14%
19,800 $20,000
Q3 2021

Nov 15, 2021
BUY
$0.67 - $1.51 $8,442 - $19,026
12,600 New
12,600 $16,000
Q2 2021

Aug 16, 2021
SELL
$0.75 - $1.1 $27,900 - $40,920
-37,200 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$0.96 - $1.74 $35,712 - $64,728
37,200 New
37,200 $39,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $117M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email